- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.70 Å
- Oligo State
- hetero-3-3-mer
- Ligands
- 3 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 12 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.2: 4 residues within 4Å:- Chain A: T.190, L.227, N.230, Y.234
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:N.230
NAG.3: 1 residues within 4Å:- Chain A: N.211
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:N.211
NAG.4: 4 residues within 4Å:- Chain A: G.237, R.239, N.241, L.246
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:N.241
NAG.5: 1 residues within 4Å:- Chain A: N.201
No protein-ligand interaction detected (PLIP)NAG.8: 4 residues within 4Å:- Chain C: T.190, L.227, N.230, Y.234
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:N.230
NAG.9: 1 residues within 4Å:- Chain C: N.211
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:N.211
NAG.10: 4 residues within 4Å:- Chain C: G.237, R.239, N.241, L.246
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:N.241
NAG.11: 1 residues within 4Å:- Chain C: N.201
No protein-ligand interaction detected (PLIP)NAG.14: 4 residues within 4Å:- Chain E: T.190, L.227, N.230, Y.234
1 PLIP interactions:1 interactions with chain E- Hydrogen bonds: E:N.230
NAG.15: 1 residues within 4Å:- Chain E: N.211
1 PLIP interactions:1 interactions with chain E- Hydrogen bonds: E:N.211
NAG.16: 4 residues within 4Å:- Chain E: G.237, R.239, N.241, L.246
1 PLIP interactions:1 interactions with chain E- Hydrogen bonds: E:N.241
NAG.17: 1 residues within 4Å:- Chain E: N.201
No protein-ligand interaction detected (PLIP)- 3 x YPS: (1R,3S,5R,7R)-N-[(1r,4R)-4-aminocyclohexyl]-3-(ethoxymethyl)-5-phenyladamantane-1-carboxamide(Non-covalent)
YPS.6: 12 residues within 4Å:- Chain A: R.37, V.39, G.40, A.74, G.75, L.159
- Chain B: L.14, Y.16, T.18, T.19, M.47, L.57
11 PLIP interactions:7 interactions with chain B, 4 interactions with chain A- Hydrophobic interactions: B:L.14, B:Y.16, B:Y.16, B:Y.16, B:Y.16, B:T.18, B:L.57, A:V.39, A:V.39, A:A.74
- Hydrogen bonds: A:R.37
YPS.12: 12 residues within 4Å:- Chain C: R.37, V.39, G.40, A.74, G.75, L.159
- Chain D: L.14, Y.16, T.18, T.19, M.47, L.57
11 PLIP interactions:4 interactions with chain C, 7 interactions with chain D- Hydrophobic interactions: C:V.39, C:V.39, C:A.74, D:L.14, D:Y.16, D:Y.16, D:Y.16, D:Y.16, D:T.18, D:L.57
- Hydrogen bonds: C:R.37
YPS.18: 12 residues within 4Å:- Chain E: R.37, V.39, G.40, A.74, G.75, L.159
- Chain F: L.14, Y.16, T.18, T.19, M.47, L.57
11 PLIP interactions:4 interactions with chain E, 7 interactions with chain F- Hydrophobic interactions: E:V.39, E:V.39, E:A.74, F:L.14, F:Y.16, F:Y.16, F:Y.16, F:Y.16, F:T.18, F:L.57
- Hydrogen bonds: E:R.37
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Abendroth, J. et al., Crystal Structure of Ebola zaire Envelope glycoprotein GP in complex with compound ARN0074953. to be published
- Release Date
- 2021-11-24
- Peptides
- GP1: ACE
GP2: BDF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
AE
AB
BD
BF
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.70 Å
- Oligo State
- hetero-3-3-mer
- Ligands
- 3 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 12 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x YPS: (1R,3S,5R,7R)-N-[(1r,4R)-4-aminocyclohexyl]-3-(ethoxymethyl)-5-phenyladamantane-1-carboxamide(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Abendroth, J. et al., Crystal Structure of Ebola zaire Envelope glycoprotein GP in complex with compound ARN0074953. to be published
- Release Date
- 2021-11-24
- Peptides
- GP1: ACE
GP2: BDF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
AE
AB
BD
BF
B